Ciprofloxacin and Dexamethasone
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Deepika Beereddy, MBBS [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Ciprofloxacin and Dexamethasone is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. Common adverse reactions include {{{adverseReactions}}}.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Acute Otitis Externa
- CIPRODEX® Otic is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in acute otitis externa in pediatric, adult and elderly patients due to Staphylococcus aureus and Pseudomonas aeruginosa.
- Dosing information:
- Otitis externa, acute: 4 drops into the affected ear twice a day for 7 days.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Ciprofloxacin and Dexamethasone in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Ciprofloxacin and Dexamethasone in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
- CIPRODEX® Otic is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below:
- Acute Otitis Media in pediatric patients (age 6 months and older) with tympanostomy tubes due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Pseudomonas aeruginosa.
- Acute Otitis Externa in pediatric (age 6 months and older) patients due to Staphylococcus aureus and Pseudomonas aeruginosa.
- Acute Otitis Media in pediatric patients (age 6 months and older) with tympanostomy tubes due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Pseudomonas aeruginosa.
Acute Otitis Media with typanostomy tube
- Dosing information:
- Acute Otitis Media in pediatric patients with tympanostomy tubes: The recommended dosage regimen for the treatment of acute otitis media in pediatric patients (age 6 months and older) through tympanostomy tubes is: Four drops (0.14 mL, 0.42 mg ciprofloxacin, 0.14 mg dexamethasone) instilled into the affected ear twice daily for seven days.
Acute Otitis Externa
- Dosing information:
- The recommended dosage regimen for the treatment of acute otitis externa is: For patients (age 6 months and older): Four drops (0.14 mL, 0.42 mg ciprofloxacin, 0.14 mg dexamethasone) instilled into the affected ear twice daily for seven days.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Ciprofloxacin and Dexamethasone in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Ciprofloxacin and Dexamethasone in pediatric patients.
Contraindications
CIPRODEX® Otic is contraindicated in patients with a history of hypersensitivity to ciprofloxacin, to other quinolones, or to any of the components in this medication. Use of this product is contraindicated in viral infections of the external canal including herpes simplex infections.
Warnings
There is limited information regarding Ciprofloxacin and Dexamethasone Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Ciprofloxacin and Dexamethasone Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Ciprofloxacin and Dexamethasone Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Ciprofloxacin and Dexamethasone Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Ciprofloxacin and Dexamethasone in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Ciprofloxacin and Dexamethasone in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Ciprofloxacin and Dexamethasone during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Ciprofloxacin and Dexamethasone in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Ciprofloxacin and Dexamethasone in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Ciprofloxacin and Dexamethasone in geriatric settings.
Gender
There is no FDA guidance on the use of Ciprofloxacin and Dexamethasone with respect to specific gender populations.
Race
There is no FDA guidance on the use of Ciprofloxacin and Dexamethasone with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Ciprofloxacin and Dexamethasone in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Ciprofloxacin and Dexamethasone in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Ciprofloxacin and Dexamethasone in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Ciprofloxacin and Dexamethasone in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Ciprofloxacin and Dexamethasone Administration in the drug label.
Monitoring
There is limited information regarding Ciprofloxacin and Dexamethasone Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Ciprofloxacin and Dexamethasone and IV administrations.
Overdosage
There is limited information regarding Ciprofloxacin and Dexamethasone overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Ciprofloxacin and Dexamethasone Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Ciprofloxacin and Dexamethasone Mechanism of Action in the drug label.
Structure
There is limited information regarding Ciprofloxacin and Dexamethasone Structure in the drug label.
Pharmacodynamics
There is limited information regarding Ciprofloxacin and Dexamethasone Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Ciprofloxacin and Dexamethasone Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Ciprofloxacin and Dexamethasone Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Ciprofloxacin and Dexamethasone Clinical Studies in the drug label.
How Supplied
There is limited information regarding Ciprofloxacin and Dexamethasone How Supplied in the drug label.
Storage
There is limited information regarding Ciprofloxacin and Dexamethasone Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Ciprofloxacin and Dexamethasone |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Ciprofloxacin and Dexamethasone |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Ciprofloxacin and Dexamethasone Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Ciprofloxacin and Dexamethasone interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Ciprofloxacin and Dexamethasone Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Ciprofloxacin and Dexamethasone Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.